NOVOGI

novoGIâ„¢ (previously NiTi Surgical Solutions) is committed to advancing patient care by providing an expanding range of comprehensive solutions for GI disease management. NiTi Surgical Solutions has developed the first major advance in closure for gastrointestinal surgery in more than 30 years. NiTi's proprietary technology represents a breakthrough in natural healing with tissue-sparing, uniform BioDynamix anastomosis. The company's unique line of products utilizes Nitinol-based elements to press together the ends of resected tissue, enabling a natural reconnection of the intestine after removing a section, for example, as part of a colon cancer treatment. The company is commercializing a family of FDA-cleared and CE-marked disposable tissue closure devices.
NOVOGI
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical Device
Founded:
1996-01-01
Address:
Netanya, HaMerkaz, Israel
Country:
Israel
Total Employee:
101+
Status:
Active
Contact:
+972-9-8603000
Email Addresses:
[email protected]
Total Funding:
18.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon OpenResty Google Adsense AddThis AdBlock Acceptable Ads Facebook Like Button
Similar Organizations
Acunon
Acunon develops medical diagnostic devices that offers vitro test for STD patients.
Holtsch Med
Holtsch Med develops reliable medical devices and drugs for the prevention, diagnosis, and healing of diseases.
MedEvent
MedEvent sells medical devices in the area of diagnostics and therapy for prostate cancer.
Current Employees Featured
Investors List
SCP Vitalife Partners
SCP Vitalife Partners investment in Series F - NovoGI
Forbion Capital Partners
Forbion Capital Partners investment in Series F - NovoGI
Israel Healthcare Ventures
Israel Healthcare Ventures investment in Series F - NovoGI
Alice Ventures
Alice Ventures investment in Series F - NovoGI
Evergreen Venture Partners
Evergreen Venture Partners investment in Series F - NovoGI
Cipio Partners
Cipio Partners investment in Series F - NovoGI